[Nivolumab (Anti-PD-1 antibody; ONO-4538/BMS-936558) in renal cancer].
The effect of the anti-PD-1 antibody, nivolumab (ONO-4538/BMS-936558) on advanced renal cancer is promising. The present manuscript summarizes the use of this new drug in immunotherapy for renal cancer.